Conclusion: There is not enough evidence to evaluate the effect of vinpocetine on survival or dependency of patients with acute stroke.
PubMed 10796369 ↗Vinpocetine
The short answer. People are split on Vinpocetine — 50% of 57 say it helped. It is most often used for focus: 83% of 36 reports say that improved. It is well studied — 13 meta-analyses on PubMed. The most common complaint is headache.
From 205 mentions in total — the rest didn't say how it went and aren't counted.
What Vinpocetine does, according to users
Of the people who reported each effect, the share who said it got better.
2 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 13 meta-analyses on PubMed ↗ · 20 randomized trials ↗
Conclusion: Based on only one small randomised controlled unconfounded study, presently there is not enough evidence to decide whether the administration of vinpocetine does or does not decrease case fatality and dependency in acute stroke.
PubMed 10456483 ↗Conclusion: There is not enough evidence to evaluate the effect of vinpocetine on survival or dependency in patients with acute ischaemic stroke.
PubMed 18253980 ↗Conclusion: Although the basic science is interesting, the evidence for beneficial effect of vinpocetine on patients with dementia is inconclusive and does not support clinical use. The drug seems to have few adverse effects at the doses used in the studies. Large studies evaluating the use of vinpocetine for people suffering from well defined types of cognitive impairment are needed to explore possible efficacy of this treatment.
PubMed 12535455 ↗9 human trials on ClinicalTrials.gov test Vinpocetine — 5 completed, 1 recruiting now. See all on ClinicalTrials.gov ↗
- The Effects of a Combination of Nootropic Ingredients on Cognition in Healthy Young Volunteers · Biomedical Enhancement · 2017
- Vinpocetine Inhibits NF-κB-dependent Inflammation in Acute Ischemic Stroke Patients · Stroke, Immunoregulation · 2015
- Chinese Assessment for Vinpocetine In Neurology · Cerebral Infarction · 2013
Reports to the FDA
Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.
15 reports name a product containing Vinpocetine (2008–2019); 9 involved hospitalization or worse. Most often reported:
- Burning sensation · 3
- Thrombosis · 2
- Dyspnoea · 2
- Hallucination · 2
- Pruritus · 2
- Fatigue · 2
A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
NIH has funded 1 research project with Vinpocetine in the title, $564,126 in total (2024–2025). NIH RePORTER ↗
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“I also noticed a big boost after introducing Vinpocetine and Huperzine A.”
“I noticed that I was feeling a bit melancholy after using it for a few weeks.”
“I tried Vinpocetine and gingko biloba for the same effect, but with cero results.”
“I didn't really see much difference in my cognitive functions using vinpo.”
Top discussions (5)
- Best bang-for-buck hacks/supplements in 2020? ↗
- I suspect, I have chronic inflammation, or something autoimmune, and it impacts my cognition significantly. Asking for your advice, on what inflammation/immune response markers I can test. ↗
- Neurogenesis ↗
- After 20 years of Nootropics use, these are the best in my experience ↗
- Top 10 most popular Nootropics in Russia ↗
Other options for focus
Sources
- User reports: 205 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- NIH RePORTER ↗
- US Food and Drug Administration: CAERS adverse-event reports ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate